cromakalim has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, K; Nishimura, K; Ota, M | 1 |
Gok, S; Gurpinar, T | 1 |
2 other study(ies) available for cromakalim and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
Article | Year |
---|---|
Existence of two components in the tonic contraction of rat aorta mediated by alpha 1-adrenoceptor activation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Benzopyrans; Calcium; Calcium Channel Blockers; Calcium Radioisotopes; Carbamates; Cromakalim; In Vitro Techniques; Isoquinolines; Lanthanum; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nifedipine; Phenylcarbamates; Phenylephrine; Phosphatidylinositols; Piperazines; Protease Inhibitors; Pyrroles; Rats | 1991 |
Vasodilator effects of cromakalim and HA 1077 in diabetic rat aorta.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Aorta; Cromakalim; Diabetes Mellitus; In Vitro Techniques; KATP Channels; Male; Muscle, Smooth, Vascular; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction; Streptozocin; Vasodilation; Vasodilator Agents | 2012 |